Shiona K Glass-Kaastra1, Rita Finley1, Jim Hutchinson2, David M Patrick3, Karl Weiss4, John Conly5. 1. Public Health Agency of Canada, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Guelph, Ontario; 2. Division of Medical Microbiology, Island Medical Program, University of British Columbia; 3. British Columbia Centre for Disease Control, Vancouver, British Columbia; ; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia; 4. University of Montreal, Department of Infectious Diseases and Microbiology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec; 5. Department of Medicine, University of Calgary, Calgary, Alberta ; Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta ; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta.
Abstract
BACKGROUND: The volume and patterns of antimicrobial drug use are key variables to consider when developing guidelines for prescribing, and programs to address stewardship and combat the increasing prevalence of antimicrobial resistant pathogens. Because drug programs are regulated at the provincial level, there is an expectation that antibiotic use may vary among provinces. OBJECTIVE: To assess these potential differences according to province and time. METHODS: Provincial antimicrobial prescribing data at the individual drug level were acquired from the Canadian Integrated Program for Antimicrobial Resistance Surveillance for 2000 to 2010. Data were used to calculate two yearly metrics: prescriptions per 1000 inhabitant-days and the average defined daily doses per prescription. The proportion of liquid oral prescriptions of total prescriptions was also calculated as a proxy measure for the proportion of prescriptions given to children versus adults. To assess the significance of provincial antimicrobial use, linear mixed models were developed for each metric, accounting for repeated measurements over time. RESULTS: Significant differences among provinces were found, as well as significant changes in use over time. Newfoundland and Labrador was found to have significantly higher prescribing rates than all other provinces (P<0.001) in 2010, as well as the mean of all other provinces (P<0.001). In contrast, Quebec exhibited significantly lower prescribing than all other provinces (P<0.001 for all provinces except British Columbia, where P=0.024) and the mean of all other provinces (P<0.001). DISCUSSION/ CONCLUSION: Reports of reductions in antimicrobial use at the Canadian level are promising, especially prescribing to children; however, care must be taken to avoid the pitfall of the ecological fallacy. Reductions are not consistent among the provinces or among the classes of antimicrobial drugs dispensed in Canada.
BACKGROUND: The volume and patterns of antimicrobial drug use are key variables to consider when developing guidelines for prescribing, and programs to address stewardship and combat the increasing prevalence of antimicrobial resistant pathogens. Because drug programs are regulated at the provincial level, there is an expectation that antibiotic use may vary among provinces. OBJECTIVE: To assess these potential differences according to province and time. METHODS: Provincial antimicrobial prescribing data at the individual drug level were acquired from the Canadian Integrated Program for Antimicrobial Resistance Surveillance for 2000 to 2010. Data were used to calculate two yearly metrics: prescriptions per 1000 inhabitant-days and the average defined daily doses per prescription. The proportion of liquid oral prescriptions of total prescriptions was also calculated as a proxy measure for the proportion of prescriptions given to children versus adults. To assess the significance of provincial antimicrobial use, linear mixed models were developed for each metric, accounting for repeated measurements over time. RESULTS: Significant differences among provinces were found, as well as significant changes in use over time. Newfoundland and Labrador was found to have significantly higher prescribing rates than all other provinces (P<0.001) in 2010, as well as the mean of all other provinces (P<0.001). In contrast, Quebec exhibited significantly lower prescribing than all other provinces (P<0.001 for all provinces except British Columbia, where P=0.024) and the mean of all other provinces (P<0.001). DISCUSSION/ CONCLUSION: Reports of reductions in antimicrobial use at the Canadian level are promising, especially prescribing to children; however, care must be taken to avoid the pitfall of the ecological fallacy. Reductions are not consistent among the provinces or among the classes of antimicrobial drugs dispensed in Canada.
Authors: Rachel M McKay; Linda Vrbova; Elaine Fuertes; Mei Chong; Samara David; Kim Dreher; Dale Purych; Edith Blondel-Hill; Bonnie Henry; Fawziah Marra; Perry Rw Kendall; David M Patrick Journal: Can J Infect Dis Med Microbiol Date: 2011 Impact factor: 2.471
Authors: Deborah Marshall; Jacqueline Gough; Paul Grootendorst; Melanie Buitendyk; Barbara Jaszewski; Susan Simonyi; Farah Jivraj; Stuart Macleod Journal: J Health Serv Res Policy Date: 2006-01
Authors: Kevin L Schwartz; Camille Achonu; Kevin Antoine Brown; Bradley Langford; Nick Daneman; Jennie Johnstone; Gary Garber Journal: CMAJ Open Date: 2018-10-31
Authors: Ariana Saatchi; Andrew M Morris; David M Patrick; James Mccormack; Romina C Reyes; Phillip Morehouse; Jennifer Reid; Salimah Shariff; Marcus Povitz; Michael Silverman; Fawziah Marra Journal: JAC Antimicrob Resist Date: 2021-08-12
Authors: Geoffrey Taylor; Denise Gravel; Lynora Saxinger; Kathryn Bush; Kimberley Simmonds; Anne Matlow; Joanne Embree; Nicole Le Saux; Lynn Johnston; Kathryn N Suh; John Embil; Elizabeth Henderson; Michael John; Virginia Roth; Alice Wong Journal: Can J Infect Dis Med Microbiol Date: 2015 Mar-Apr Impact factor: 2.471
Authors: Shiona K Glass-Kaastra; Rita Finley; Jim Hutchinson; David M Patrick; Karl Weiss; John Conly Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240